NCT02851888

Brief Summary

The purpose of this research is to determine differences in outcomes in patients who do, or do not, receive regional anesthesia (a fascia iliaca block) prior to undergoing hip arthroscopy with labral repair and/or debridement and osteoplasty for hip impingement

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
70

participants targeted

Target at P25-P50 for phase_4

Timeline
Completed

Started Jul 2016

Typical duration for phase_4

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2016

Completed
25 days until next milestone

First Submitted

Initial submission to the registry

July 26, 2016

Completed
7 days until next milestone

First Posted

Study publicly available on registry

August 2, 2016

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2018

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2018

Completed
Last Updated

February 19, 2018

Status Verified

November 1, 2017

Enrollment Period

1.8 years

First QC Date

July 26, 2016

Last Update Submit

February 14, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • Pain Medication Requirement in PACU

    Measured in morphine equivalents

    24 hours post-operatively

Secondary Outcomes (9)

  • Falls

    6 weeks

  • Readmissions

    6 weeks

  • Neuropathic Pain

    2 weeks and 6 weeks

  • Time to Physical Therapy

    6 weeks

  • Duration of PACU stay (mins)

    24 hours post-operatively

  • +4 more secondary outcomes

Study Arms (2)

Iliac Fascia Block (Ropivacaine)

EXPERIMENTAL

These patients will receive a preoperative iliac fascia block performed as a single shot in the standard fashion prior to hip arthroscopy with general anesthesia.

Drug: RopivacaineProcedure: General Anesthesia

Control (Normal Saline Sham Injection)

SHAM COMPARATOR

These patients will receive a preoperative sham block of normal saline in the same fashion as a standard singl shot iliac fascia block prior to hip arthroscopy with general anesthesia.

Other: Normal Saline Sham InjectionProcedure: General Anesthesia

Interventions

Iliac fascia block was performed in the experimental group with a single shot of Ropavicaine.

Also known as: Iliac Fascia Block
Iliac Fascia Block (Ropivacaine)

Sham block using normal saline instead of iliac fascia block but otherwise employing the equivalent technique.

Control (Normal Saline Sham Injection)

Patients were induced and maintained in a fashion consistent with standard practices.

Control (Normal Saline Sham Injection)Iliac Fascia Block (Ropivacaine)

Eligibility Criteria

Age18 Years - 50 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Scheduled for arthroscopic labral repair with or without osteoplasty of the hip.
  • to 50 years old
  • American Society of Anesthesiologists Physical Status (ASA PS) score of I or II.

You may not qualify if:

  • Current or planned pregnancy
  • History of neuropathic pain, chronic pain syndrome, or preoperative use of narcotic or neuropathic pain medicine
  • Radiographic signs of osteoarthritis (\> Tonis grade 1)
  • Inability to attend follow up visits
  • Documented allergy to local anesthetic

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Georgetown University Medical Center

Washington D.C., District of Columbia, 20007, United States

RECRUITING

MeSH Terms

Conditions

Hip Injuries

Interventions

RopivacaineAnesthesia, General

Condition Hierarchy (Ancestors)

Wounds and Injuries

Intervention Hierarchy (Ancestors)

AnilidesAmidesOrganic ChemicalsAniline CompoundsAminesAnesthesiaAnesthesia and Analgesia

Study Officials

  • Blake Bodendorfer, MD

    Georgetown University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

John G Mawn, BS

CONTACT

Jessica B Hawken, BA

CONTACT

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 26, 2016

First Posted

August 2, 2016

Study Start

July 1, 2016

Primary Completion

April 1, 2018

Study Completion

August 1, 2018

Last Updated

February 19, 2018

Record last verified: 2017-11

Data Sharing

IPD Sharing
Will not share

Locations